Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
May
7
2024
 Courts Neutralize Baseless Acid Lawsuits Proskauer Rose LLP
May
7
2024
 Singapore Introduces New Legislation Regulating Food Alternative Proteins and More Keller and Heckman LLP
May
7
2024
 FDA Finalizes Ag Water Rule Keller and Heckman LLP
May
7
2024
 Live from Workplace Horizons 2024 - Episode 1: What Employers Need to Know About Keeping Your Workplace Safe, Drug-Free, and Productive [Podcast] Jackson Lewis P.C.
May
6
2024
 Old North State Report – May 6, 2024 Nelson Mullins
May
6
2024
 Healthcare Preview for the Week of: May 6, 2024 [Podcast] McDermott Will & Schulte LLP
May
6
2024
 FDA’s Final LDT Rule Is Here, and the Changes Show the Agency Is Serious and Actually Listening to Stakeholders Mintz
May
6
2024
 A New Day for “Natural” Claims? Keller and Heckman LLP
May
6
2024
 FDA Finalizes Rule Regulating Laboratory Developed Tests Polsinelli PC
May
3
2024
 Congress Extends Statute of Limitations for Sanctions Violations Hunton Andrews Kurth
May
3
2024
 Second Circuit Upholds Summary Judgment for Defendants Against Allegations That "All Natural" Label Was Misleading Mintz
May
3
2024
 McdermottPlus Check-Up: May 3, 2024 McDermott Will & Schulte LLP
May
2
2024
 And They’re (Almost) Off! Kentucky’s Medical Cannabis Applications Due Soon Bradley Arant Boult Cummings LLP
May
2
2024
 CIPL Publishes Report on Enabling Beneficial and Safe Uses of Biometric Technology Through Risk-Based Regulations Hunton Andrews Kurth
May
2
2024
 DEA Accepts HHS Recommendation to Reschedule Cannabis [Podcast] Womble Bond Dickinson (US) LLP
May
1
2024
 ChemCatBio Seeks Community Feedback on Local Manufacturing Bergeson & Campbell, P.C.
May
1
2024
 DOJ Plans to Reclassify Marijuana From Schedule I to Lower-Risk Schedule III Drug Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
1
2024
 Spring Has Sprung Obviousness Trends from the Federal Circuit Bradley Arant Boult Cummings LLP
May
1
2024
 Lawsuit Targets 100% Juice Claim Keller and Heckman LLP
May
1
2024
 FDA Issues Final Rule Regulating Many Laboratory-Developed Tests as Medical Devices McDermott Will & Schulte LLP
Apr
30
2024
 FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests Sheppard, Mullin, Richter & Hampton LLP
Apr
30
2024
 DEA Poised to Reschedule Marijuana Bradley Arant Boult Cummings LLP
Apr
30
2024
 Carbon Quarterly - Volume 8 K&L Gates LLP
Apr
30
2024
 This Week in 340B: April 23 – April 29, 2024 McDermott Will & Schulte LLP
Apr
30
2024
 Mixed Algae Conversion Research Opportunity Will Award up to $18.8 Million to Address R&D Challenges in Converting Algae to Biofuels and Bioproducts Bergeson & Campbell, P.C.
Apr
30
2024
 It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices Has Arrived Epstein Becker & Green, P.C.
Apr
30
2024
 FSIS Declares Salmonella an Adulterant in Chicken Products Keller and Heckman LLP
Apr
30
2024
 Will California’s Proposed Acrylamide Warning Amendment Under Proposition 65 Pass Legal Muster? ArentFox Schiff LLP
Displaying 1541 - 1568 of 12618
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters